Article

Mmarketwatch.com on 2019-03-20 15:50

Shares of Sage Therapeutics up on Zulresso approval, but analysts expect a slow rollout

Shares of Sage Therapeutics Inc. rose 3.2% Wednesday morning after the company’s announcement Tuesday evening that the Food and Drug Administration had...

Wall Street

Related news

BSarepta Therapeutics Drops on Earnings. Why Analysts Remain Hopeful.barrons.com
Wall Street
FDA Approves Sage Therapeutics’ Zulresso wsj.com
Sage Therapeutics, Dollar General jump; LendingClub tumbles Chicago Tribune
Wall Street , Dollar General
United Therapeutics scores another FDA approval bizjournals.com
IHere’s why Sage Therapeutics fell 18% on Tuesday morning invezz.com
Expect swings, lower returns, analysts warn triblive.com
Brazil , Japan , Europe , China , Wall Street
DAnalysts expect fireworks when Nvidia reports earnings dcourier.com
Wall Street
BNeos Therapeutics stock soars on FDA approval for ADHD drug bizbeatblog.dallasnews.com
Ireland
TAxsome Therapeutics (Finally) Earns Approval. Here’s What’s Next thestreet.com
Germany , United Kingdom
United Therapeutics just earned a long-awaited FDA approval bizjournals.com
Cincinnati Children’s spinout, Airway Therapeutics, receives key FDA approval bizjournals.com
Cincinnati
United Therapeutics gets another FDA approval for pulmonary hypertension therapy bizjournals.com
Newest FDA approval could boost Partner Therapeutics' Lynnwood plant bizjournals.com
Lynnwood
HSPR Therapeutics wins FDA approval for pain treatment system home.crainscleveland.com
FDA advisory panel recommends approval of Spark Therapeutics' gene therapy bizjournals.com
Cesca Therapeutics gets patent, approval to start clinical trial bizjournals.com
Sacramento , India
MPTC Therapeutics gains after FDA panel votes against drug approval marketwatch.com